Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10080	Companies
206103	Keywords
136322	Articles
109258	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 02/25/2025 at 07:00, 1 year ago

Biophytis annonce sa participation au 15ème Congrès International sur la Fragilité et la Sarcopénie (ICFSR)
Biophytis participera au 15ème Congrès ICFSR pour présenter BIO101 dans la sarcopénie associée à l’obésité. La société de biotechnologie se concentre sur le développement de traitements pour les maladies liées à l'âge

Biophytis Sarcopénie Maladies Liées À L'âge Obésité Congrès ICFSR
REGULATED PRESS RELEASE

published on 02/25/2025 at 07:00, 1 year ago

Biophytis announces its participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)
Biophytis to participate in ICFSR 15th International Conference on Frailty and Sarcopenia Research, presenting data on BIO101 for obesity-associated sarcopenia. Event in Toulouse, March 12-14

Biophytis Sarcopenia ICFSR BIO101 Obesity
BRIEF

published on 02/11/2025 at 07:05, 1 year 1 month ago

Biophytis annonce ses priorités stratégiques pour 2025

Biophytis Partenariats Stratégie 2025 Sarcopénie Obésité
BRIEF

published on 02/11/2025 at 07:05, 1 year 1 month ago

Biophytis Outlines 2025 Strategic Plans

Strategic Partnerships Biophytis Clinical Development Obesity Treatment Sarcopenia
REGULATED PRESS RELEASE

published on 02/11/2025 at 07:00, 1 year 1 month ago

Biophytis dévoile ses perspectives stratégiques de l’année 2025
Biophytis dévoile ses perspectives stratégiques pour l’année 2025, incluant le lancement de nouveaux programmes cliniques et des collaborations clés dans le domaine des maladies liées à l'âge

Stratégie Biophytis Partenariats Développement Clinique Maladies Liées À L'âge
REGULATED PRESS RELEASE

published on 02/11/2025 at 07:00, 1 year 1 month ago

Biophytis unveils its outlook strategies for 2025
Biophytis unveils its strategic outlook for 2025, focusing on clinical development and commercialization plans for BIO101 (20-Hydroxyecdysone) in obesity and sarcopenia, with key partnerships and agreements

Biophytis Clinical Development BIO101 Obesity Strategic Outlook
BRIEF

published on 01/27/2025 at 07:05, 1 year 1 month ago

Biophytis to Participate in BIOMED FORUM Investor Conference

Biophytis Investor Conference Healthcare Sector Paris BIOMED Forum
BRIEF

published on 01/27/2025 at 07:05, 1 year 1 month ago

Biophytis participe à la conférence Biomed Forum à Paris

Biophytis Biotechnologie Investisseurs BIOMED Forum Santé
REGULATED PRESS RELEASE

published on 01/27/2025 at 07:00, 1 year 1 month ago

Biophytis announces its participation to the BIOMED FORUM investor conference
Biophytis announces participation in Biomed Forum investor conference to engage with investors and share updates on developments for age-related diseases

Biophytis Investor Conference Healthcare Sector BIOMED Forum Age-related Diseases
REGULATED PRESS RELEASE

published on 01/27/2025 at 07:00, 1 year 1 month ago

Biophytis annonce sa participation à la conférence investisseurs BIOMED FORUM
Biophytis annonce sa participation à la conférence investisseurs BIOMED FORUM, occasion de rencontrer des investisseurs pour présenter les avancées et perspectives 2025

Biophytis Biotechnologie Investisseurs BIOMED Forum Conference

Accesswire

Published on 03/24/2026 at 13:30, 1 hour 39 minutes ago

GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 1 hour 39 minutes ago

Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 2 hours 34 minutes ago

Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 2 hours 36 minutes ago

Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 2 hours 39 minutes ago

Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 14:50, 19 minutes ago

CoinShares Digital Securities Limited: EU CSDSL Individual - Additional Custodian (24.03)
Published on 03/24/2026 at 14:45, 24 minutes ago

CoinShares Digital Securities Limited: EU CSDSL Index - Additional Custodian (24/03/2026)
Published on 03/24/2026 at 14:39, 30 minutes ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY
Published on 03/24/2026 at 14:30, 39 minutes ago

EQS-Adhoc: Sibanye Gold Limited: USD 500,000,000 4.250 per cent. Guaranteed Unsecured Convertible Bonds due 2028
Published on 03/24/2026 at 14:28, 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Les Echos

Published on 03/24/2026 at 10:58, 4 hours 11 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 4 hours 11 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 7 hours 24 minutes ago

François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 7 hours 24 minutes ago

La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 7 hours 39 minutes ago

Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions

View all LES ECHOS COMFI WIRE